Search results for "FDA update"
January 2018
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2018/01/
January 2020
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2020/01/
August 2020
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2020/08/
July 2018
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2018/07/
June 2021
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2021/06/
July 2021
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2021/07/
Antibiotic OKed for pneumonia, bloodstream, skin infections
In addition to approving ceftobiprole medocaril sodium for three different types of infection, the FDA authorized the first generic version of fidaxomicin, among other actions.
https://acphospitalist.acponline.org/archives/2024/04/10/antibiotic-oked-for-pneumonia-bloodstream-skin-infections.htm
10 Apr 2024
First medication for severe frostbite approved
The FDA also warned about smartwatches claiming to measure blood sugar without piercing the skin, among other recent actions.
https://acphospitalist.acponline.org/archives/2024/03/06/first-medication-for-severe-frostbite-approved.htm
6 Mar 2024
FDA update: Defibrillator recall expanded
Drug recalls, warnings, approvals.
https://acphospitalist.acponline.org/archives/2010/07/fda.htm
15 Jul 2010
New COVID-19 boosters, biosimilar for MS OK’ed
The FDA approved updated COVID-19 vaccines and the first-ever biosimilar for multiple sclerosis (MS), among other recent actions.
https://acphospitalist.acponline.org/archives/2023/10/04/new-covid-19-boosters-biosimilar-for-ms-oked.htm
4 Oct 2023